Steven Michael Devine
Impact in
- Hematology top 0.02%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Genetics top 0.1%
- Mesenchymal stem cell research
Papers in
- Hematology 264
- Hematopoietic Stem Cell Transplantation 188
- Acute Myeloid Leukemia Research 99
- Multiple Myeloma Research and Treatments 33
- Genetics 78
- Chronic Lymphocytic Leukemia Research 35
- Co-authors
- Ron Hoffman (4 shared papers)John F. DiPersio (43 shared papers)Amelia M. Bartholomew (5 shared papers)Matt Jennings (1 shared paper)Craig C. Hofmeister (34 shared papers)Hillard Michael Lazarus (15 shared papers)Mary M. Horowitz (22 shared papers)Mehdi Hamadani (22 shared papers)
- Journals
- Blood (103 papers)Transplantation and Cellular Therapy (101 papers)Bone Marrow Transplantation (34 papers)Journal of Clinical Oncology (21 papers)Blood Advances (19 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Steven Michael Devine
389 papers receiving 21.2k citations
Steven Michael Devine's Hit Papers
Peers
Comparison fields: 5 of 144
- Hematology 12.8k
- Genetics 4.5k
- Transplantation 902
- Immunology 5.0k
- Oncology 5.8k
Countries citing papers authored by Steven Michael Devine
This map shows the geographic impact of Steven Michael Devine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Michael Devine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Michael Devine more than expected).
Fields of papers citing papers by Steven Michael Devine
This network shows the impact of papers produced by Steven Michael Devine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Michael Devine. The network helps show where Steven Michael Devine may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Michael Devine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 401 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma Hit paper breakdown → | 2012 | 932 |
| 2 | The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody Hit paper breakdown → | 2010 | 712 |
| 3 | International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium Hit paper breakdown → | 2015 | 709 |
| 4 | Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients Hit paper breakdown → | 2005 | 668 |
| 5 | Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates Hit paper breakdown → | 2003 | 633 |
| 6 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Hit paper breakdown → | 2015 | 550 |
| 7 | Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes Hit paper breakdown → | 2017 | 537 |
| 8 | Current Use of and Trends in Hematopoietic Cell Transplantation in the United States Hit paper breakdown → | 2020 | 520 |
| 9 | Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts Hit paper breakdown → | 2011 | 487 |
| 10 | Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Hit paper breakdown → | 1998 | 479 |
| 11 | 2013 | 404 | |
| 12 | 2010 | 404 | |
| 13 | Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial Hit paper breakdown → | 2013 | 386 |
| 14 | 2001 | 365 | |
| 15 | 2004 | 357 | |
| 16 | 2017 | 356 | |
| 17 | Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease Hit paper breakdown → | 2019 | 352 |
| 18 | 2013 | 311 | |
| 19 | 2011 | 305 | |
| 20 | 2014 | 277 |
About Steven Michael Devine
Steven Michael Devine is a scholar working on Hematology, Genetics, Oncology, Immunology and Transplantation, having authored 401 papers that have together received 21.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (188 papers), Acute Myeloid Leukemia Research (99 papers), Acute Lymphoblastic Leukemia research (60 papers), Lymphoma Diagnosis and Treatment (46 papers), Immune Cell Function and Interaction (36 papers), Chronic Lymphocytic Leukemia Research (35 papers), Renal Transplantation Outcomes and Treatments (33 papers) and Multiple Myeloma Research and Treatments (33 papers). The work is most often cited by research in Hematology (12.8k citations), Genetics (4.5k citations), Transplantation (902 citations), Immunology (5.0k citations) and Oncology (5.8k citations). Steven Michael Devine has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Ron Hoffman, John F. DiPersio, Amelia M. Bartholomew, Matt Jennings, Craig C. Hofmeister, Hillard Michael Lazarus, Mary M. Horowitz, Mehdi Hamadani, Richard Thomas Maziarz and Brent R. Logan. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, Journal of Clinical Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.